Case Type: Mergers & Acquisitions

We are investigating Spark Therapeutics, Inc. (NasdaqGS: ONCE) relating to the sale of the Company to Roche Holdings, Inc. Under the terms of the agreement, Spark Therapeutics shareholders are only anticipated to receive $114.50 in cash for each share of Spark Therapeutics they own.

We are investigating the Board of Directors of SunCoke Energy Partners, L.P. (NYSE: SXCP) related to the sale of the company to SunCoke Energy, Inc. Under the terms of the proposed transaction, SunCoke Energy Partners stockholders will receive 1.40 shares of SunCoke Energy, Inc. for each share of SunCoke Energy Partners common stock owned.

We are investigating the Board of Directors of Top Image Systems Ltd. (NasdaqCM: TISA) related to the sale of the company to Kofax Holdings International Ltd. Under the terms of the proposed transaction, Top Image stockholders will receive $0.86 in cash for each ordinary share of Top Image.

We are investigating the Board of Directors of Determine, Inc. (Other: DTRM) related to the sale of the company to Corcentric Acquisition, LLC. Under the terms of the proposed transaction, Determine has agreed to sell substantially all of its assets to Corcentric for a cash purchase price of $32,000,000.

We are investigating the Board of Directors of Churchill Capital Corp (NYSE: CCC ) related to the sale of the company to Clarivate Analytics PLC. Under the terms of the proposed transaction, each outstanding share of common stock of Churchill will be converted into one ordinary share of Clarivate.

We are investigating the Board of Directors of Blue Valley Ban Corp. (Other: BVBC) related to the sale of the company to Heartland Financial USA, Inc. Under the terms of the proposed transaction, each share of Blue Valley common stock will receive 0.3271 shares of Heartland common stock.

We are investigating the Board of Directors of Immune Design Corp. (NasdaqGS: IMDZ) regarding its sale to Merck Sharp & Dohme Corp. for $5.85 per each share of Immune Design Corp.

We are investigating the Board of Directors of Ellie Mae, Inc. (NasdaqGM: ELLI) regarding its sale to EM Eagle Purchaser, LLC. for $99.00 per each share of Ellie Mae Stock.

We are investigating the Board of Directors of CAS Medical Systems, Inc. (NasdaqGS: CASM) regarding its sale to Edwards Lifesciences Holding, Inc. for $2.45 per each share of CAS Medical Systems.

We are investigating The Ultimate Software Group, Inc. (NYSE: ULTI) regarding its sale to Unite Parent Corp. for $331.50 per each share of Ultimate Software.